Filing Details
- Accession Number:
- 0001209191-15-082995
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-12-02 18:44:03
- Reporting Period:
- 2015-12-01
- Filing Date:
- 2015-12-02
- Accepted Time:
- 2015-12-02 18:44:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1469443 | Arcadia Biosciences Inc. | RKDA | Agricultural Chemicals (2870) | 810571538 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1640658 | C. Vic Knauf | C/O Arcadia Biosciences, Inc. 202 Cousteau Place, Suite 105 Davis CA 95618 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-12-01 | 6,300 | $1.08 | 53,434 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-12-01 | 6,300 | $3.89 | 47,134 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-12-02 | 8,700 | $1.08 | 55,834 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-12-02 | 8,700 | $4.10 | 47,134 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2015-12-01 | 6,300 | $0.00 | 6,300 | $1.08 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2015-12-02 | 8,700 | $0.00 | 8,700 | $1.08 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 246,200 | 2018-06-30 | No | 4 | M | Direct | |
| 237,500 | 2018-06-30 | No | 4 | M | Direct |
Footnotes
- The security transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Stock Trading Plan (the "Plan"), adopted by the Reporting Person effective June 12, 2015.
- This transaction was executed in multiple trades at prices ranging from $3.78 to $3.99. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $3.91 to $4.24. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The option is fully exercisable as of the date hereof.
Billionaire Hedge Funds
